Psilera

About:

Psilera is delivering next-generation psychedelics at home using a platform approach to derisk and scale the drug discovery & design process

Website: http://www.psilera.com

Twitter/X: psilera

Top Investors: Florida High Tech Corridor, What If Ventures, JLS Fund, Mystic Ventures, Baird Inc

Description:

Psilera is reimagining psychoactive natural products as building blocks for a new generation of mindful medicine. Many pharmaceutical drugs originate from nature due to intrinsic biodiversity, biological activity, and safety that have been optimized throughout time. Psilera is leveraging its research strengths with executives from the pharmaceutical and cannabis industries to develop a best-in-class IP portfolio of analogs based on psychoactive precursors. Lead compounds are formulated and screened against neurological targets to evaluate clinical potential with pipeline candidates in the areas of mood disorders, cognitive diseases, and addiction. Psilera’s mission is to make a significant impact on mental health and reduce human suffering.

Total Funding Amount:

$2.63M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tampa, Florida, United States

Founded Date:

2019-07-01

Contact Email:

info(AT)psilera.com

Founders:

Christopher Witowski, Jacqueline von Salm

Number of Employees:

1-10

Last Funding Date:

2022-11-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai